Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.

Br J Cancer · 1992 · PMC1977407 · PMID 1419619

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)

The terminal half life was, how- ever, significantly longer in the patients with a raised AST than in those with normal liver biochemistry (P = 0.05). There was a trend for MRT to be longer in group 2 than in group 1, but this did not reach statistical significance (P = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.